These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

917 related items for PubMed ID: 17712057

  • 1. Vasopressin dysregulation and hyponatremia in hospitalized patients.
    Multz AS.
    J Intensive Care Med; 2007; 22(4):216-23. PubMed ID: 17712057
    [Abstract] [Full Text] [Related]

  • 2. Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism.
    Rai A, Whaley-Connell A, McFarlane S, Sowers JR.
    Am J Nephrol; 2006; 26(6):579-89. PubMed ID: 17170524
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vasopressin excess and hyponatremia.
    Pham PC, Pham PM, Pham PT.
    Am J Kidney Dis; 2006 May; 47(5):727-37. PubMed ID: 16632011
    [Abstract] [Full Text] [Related]

  • 7. The use of vasopressin receptor antagonists in hyponatremia.
    Khanna A, Menon MC.
    Curr Opin Investig Drugs; 2010 Sep; 11(9):1007-14. PubMed ID: 20730695
    [Abstract] [Full Text] [Related]

  • 8. Hyponatremia and hypernatremia: disorders of water balance.
    Agrawal V, Agarwal M, Joshi SR, Ghosh AK.
    J Assoc Physicians India; 2008 Dec; 56():956-64. PubMed ID: 19322975
    [Abstract] [Full Text] [Related]

  • 9. Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
    Palm C, Pistrosch F, Herbrig K, Gross P.
    Am J Med; 2006 Jul; 119(7 Suppl 1):S87-92. PubMed ID: 16843091
    [Abstract] [Full Text] [Related]

  • 10. Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis.
    Robertson GL.
    Am J Med; 2006 Jul; 119(7 Suppl 1):S36-42. PubMed ID: 16843083
    [Abstract] [Full Text] [Related]

  • 11. Recognition and treatment of hyponatremia in acutely ill hospitalized patients.
    Patel GP, Balk RA.
    Clin Ther; 2007 Feb; 29(2):211-29. PubMed ID: 17472815
    [Abstract] [Full Text] [Related]

  • 12. [Current considerations in syndrome of inappropriate secretion of antidiuretic hormone/syndrome of inappropriate antidiuresis].
    Velasco Cano MV, Runkle de la Vega I.
    Endocrinol Nutr; 2010 May; 57 Suppl 2():22-9. PubMed ID: 21130959
    [Abstract] [Full Text] [Related]

  • 13. Neurological impact of vasopressin dysregulation and hyponatremia.
    Bhardwaj A.
    Ann Neurol; 2006 Feb; 59(2):229-36. PubMed ID: 16437573
    [Abstract] [Full Text] [Related]

  • 14. Hyponatremia and arginine vasopressin dysregulation: mechanisms, clinical consequences, and management.
    Miller M.
    J Am Geriatr Soc; 2006 Feb; 54(2):345-53. PubMed ID: 16460390
    [Abstract] [Full Text] [Related]

  • 15. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
    Wong F, Blei AT, Blendis LM, Thuluvath PJ.
    Hepatology; 2003 Jan; 37(1):182-91. PubMed ID: 12500203
    [Abstract] [Full Text] [Related]

  • 16. Vasopressin-receptor antagonists.
    Hoorn EJ, Zietse R.
    Future Cardiol; 2010 Jul; 6(4):523-34. PubMed ID: 20608824
    [Abstract] [Full Text] [Related]

  • 17. Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review.
    Nemerovski C, Hutchinson DJ.
    Clin Ther; 2010 Jun; 32(6):1015-32. PubMed ID: 20637957
    [Abstract] [Full Text] [Related]

  • 18. Current treatments and novel pharmacologic treatments for hyponatremia in congestive heart failure.
    Goldsmith SR.
    Am J Cardiol; 2005 May 02; 95(9A):14B-23B. PubMed ID: 15847853
    [Abstract] [Full Text] [Related]

  • 19. Vasopressin antagonists: role in the management of hyponatremia.
    Yeates KE, Morton AR.
    Am J Nephrol; 2006 May 02; 26(4):348-55. PubMed ID: 16837788
    [Abstract] [Full Text] [Related]

  • 20. Lixivaptan, a non-peptide vasopressin V2 receptor antagonist for the potential oral treatment of hyponatremia.
    Ghali JK, Zmily HD, Farah JO, Daifallah S.
    IDrugs; 2010 Nov 02; 13(11):782-92. PubMed ID: 21046526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.